Indeed, recent data from the German CML-Study IV have shown that achievement of confirmed MR4,5 at 4 years predicted significantly higher survival probabilities compared with cases who only achieved 0.1–1% BCR–ABLIS. Here, BCR is linked to chronic myelogenous leukemia, BCR-ABL1 positive.